Robert H. Bradbury

2.0k total citations
34 papers, 623 citations indexed

About

Robert H. Bradbury is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Robert H. Bradbury has authored 34 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Robert H. Bradbury's work include Quinazolinone synthesis and applications (8 papers), Synthesis and Biological Evaluation (8 papers) and HER2/EGFR in Cancer Research (7 papers). Robert H. Bradbury is often cited by papers focused on Quinazolinone synthesis and applications (8 papers), Synthesis and Biological Evaluation (8 papers) and HER2/EGFR in Cancer Research (7 papers). Robert H. Bradbury collaborates with scholars based in United Kingdom, France and United States. Robert H. Bradbury's co-authors include Neil J. Hales, John S. Major, Peter Ballard, Timothy Gallagher, Michael Robert Dennis, Donald Ogilvie, Teresa Klinowska, Jason G. Kettle, Laurent Hennequin and William O. Moss and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Robert H. Bradbury

34 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert H. Bradbury United Kingdom	15	343	279	153	69	47	34	623
Robert A. Mantei United States	15	258 0.8×	308 1.1×	111 0.7×	62 0.9×	32 0.7×	24	621
Fumihiko Watanabe Japan	14	381 1.1×	310 1.1×	220 1.4×	33 0.5×	43 0.9×	35	860
Carl Crysler United States	19	325 0.9×	304 1.1×	145 0.9×	53 0.8×	10 0.2×	37	782
Robert T. Lum United States	16	329 1.0×	332 1.2×	135 0.9×	30 0.4×	29 0.6×	19	759
Clive McCarthy United Kingdom	16	271 0.8×	255 0.9×	68 0.4×	64 0.9×	99 2.1×	29	673
Laura Maccari Italy	16	225 0.7×	337 1.2×	119 0.8×	117 1.7×	41 0.9×	24	662
Wasyl Halczenko United States	13	352 1.0×	448 1.6×	72 0.5×	56 0.8×	22 0.5×	49	1.0k
Robert B. Garland United States	15	479 1.4×	463 1.7×	159 1.0×	21 0.3×	15 0.3×	26	925
Daniel D. Holsworth United States	15	187 0.5×	592 2.1×	133 0.9×	72 1.0×	10 0.2×	36	865
Wayne Vaccaro United States	23	648 1.9×	565 2.0×	144 0.9×	52 0.8×	14 0.3×	37	1.2k

Countries citing papers authored by Robert H. Bradbury

Since Specialization

Citations

This map shows the geographic impact of Robert H. Bradbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Bradbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Bradbury more than expected).

Fields of papers citing papers by Robert H. Bradbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Bradbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Bradbury. The network helps show where Robert H. Bradbury may publish in the future.

Co-authorship network of co-authors of Robert H. Bradbury

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Bradbury. A scholar is included among the top collaborators of Robert H. Bradbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Bradbury. Robert H. Bradbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Connor, Lenka Oplustil, Stuart L. Rulten, Aaron Cranston, et al.. (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer Research. 76(20). 6084–6094. 60 indexed citations

Callis, Rowena, Alfred A. Rabow, Michael Tonge, et al.. (2015). A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs). SLAS DISCOVERY. 20(6). 748–759. 22 indexed citations

Barlaam, Bernard, Judith Anderton, Peter Ballard, et al.. (2013). Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors. ACS Medicinal Chemistry Letters. 4(8). 742–746. 31 indexed citations

Bradbury, Robert H., Neil J. Hales, Alfred A. Rabow, et al.. (2011). Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters. 21(18). 5442–5445. 36 indexed citations

Barlaam, Bernard, David Acton, Peter Ballard, et al.. (2008). Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1799–1803. 10 indexed citations

Bradbury, Robert H.. (2007). 1 Topics in Medicinal Chemistry. 4 indexed citations

Barlaam, Bernard, Peter Ballard, Robert H. Bradbury, et al.. (2007). A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(2). 674–678. 18 indexed citations

Ballard, Peter, Bernard Barlaam, Robert H. Bradbury, et al.. (2007). Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 17(22). 6326–6329. 23 indexed citations

Ballard, Peter, Robert H. Bradbury, Craig S. Harris, et al.. (2006). Inhibitors of epidermal growth factor receptor tyrosine kinase: Optimisation of potency and in vivo pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 16(18). 4908–4912. 29 indexed citations

10.

Ballard, Peter, Robert H. Bradbury, Craig S. Harris, et al.. (2005). Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket. Bioorganic & Medicinal Chemistry Letters. 16(6). 1633–1637. 31 indexed citations

11.

Ballard, Peter, Robert H. Bradbury, Laurent Hennequin, et al.. (2005). 5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 15(19). 4226–4229. 31 indexed citations

12.

Bradbury, Robert H., Roger J. Butlin, Michael Robert Dennis, et al.. (1997). New Non-Peptide Endothelin-A Receptor Antagonists: Synthesis, Biological Properties, and Structure−Activity Relationships of 5-(Dimethylamino)-N-pyridyl-, -N-pyrimidinyl-, -N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides. Journal of Medicinal Chemistry. 40(6). 996–1004. 23 indexed citations

13.

Bradbury, Robert H., Michael Robert Dennis, Eric F. Fisher, et al.. (1993). Quinoline, 1,5-naphthyridine and pyridine derivatives as potent, nonpeptidic angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 899–904. 8 indexed citations

14.

Bradbury, Robert H., et al.. (1993). New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives. Journal of Medicinal Chemistry. 36(9). 1245–1254. 58 indexed citations

15.

Moss, William O., Mary F. Mahon, Kieran C. Molloy, et al.. (1992). 2-Amino ketene S,S-acetals as α-amino acid homoenolate equivalents. Synthesis of 3-substituted prolines and molecular structure of 2-(N-pivaloylpyrrolidin-2-ylidene)-1,3-dithiane. Journal of the Chemical Society Perkin Transactions 1. 2615–2624. 13 indexed citations

16.

Moss, William O., Robert H. Bradbury, Neil J. Hales, & Timothy Gallagher. (1992). Ketene S,S-acetals as 1,3-dipolarophiles: application to the synthesis of polyhydroxylated pyrrolidines. Journal of the Chemical Society Perkin Transactions 1. 1901–1901. 9 indexed citations

17.

Roberts, D. Allen, Robert H. Bradbury, David Brown, et al.. (1990). 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives. Journal of Medicinal Chemistry. 33(9). 2326–2334. 7 indexed citations

18.

Bradbury, Robert H., John S. Major, David A. Roberts, et al.. (1990). 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives. Journal of Medicinal Chemistry. 33(9). 2335–2342. 12 indexed citations

19.

Moss, William O., Robert H. Bradbury, Neil J. Hales, & Timothy Gallagher. (1988). Ketene-S,S-acetals as 1,3-dipolarophiles. Reactivity towards electron-deficient azides.. Tetrahedron Letters. 29(49). 6475–6478. 9 indexed citations

20.

Bradbury, Robert H., T. L. Gilchrist, & Charles W. Rees. (1979). Isolation and thermal rearrangement of a 4aH-benzocycloheptene. Journal of the Chemical Society Chemical Communications. 528–528. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact